195 related articles for article (PubMed ID: 27598486)
1. [Neutrophil/lymphocyte ratio in complete blood count as a mortality predictor in breast cancer].
Mimica X; Acevedo F; Oddo D; Ibáñez C; Medina L; Kalergis A; Camus M; Sánchez C
Rev Med Chil; 2016 Jun; 144(6):691-6. PubMed ID: 27598486
[TBL] [Abstract][Full Text] [Related]
2. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant setting.
Koh YW; Lee HJ; Ahn JH; Lee JW; Gong G
Tumour Biol; 2014 Oct; 35(10):9823-30. PubMed ID: 24986572
[TBL] [Abstract][Full Text] [Related]
4. High neutrophil-to-lymphocyte ratio predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy.
Yao A; Sejima T; Iwamoto H; Masago T; Morizane S; Honda M; Takenaka A
Int J Urol; 2015 Sep; 22(9):827-33. PubMed ID: 26087772
[TBL] [Abstract][Full Text] [Related]
5. Associations between absolute neutrophil count and lymphocyte-predominant breast cancer.
Yoon CI; Park S; Cha YJ; Lee HS; Bae SJ; Cha C; Lee DY; Ahn SG; Jeong J
Breast; 2020 Apr; 50():141-148. PubMed ID: 31607527
[TBL] [Abstract][Full Text] [Related]
6. PERCEPTION Trial protocol: Comparison of predictive and prognostic capacities of neutrophil, lymphocyte, and platelet counts and tumor-infiltrating lymphocytes in triple negative breast cancer.
Lusho S; Durando X; Bidet Y; Molnar I; Kossai M; Bernadach M; Lacrampe N; Veyssiere H; Cavaille M; Gay-Bellile M; Radosevic-Robin N; Abrial C
Medicine (Baltimore); 2020 Dec; 99(50):e23418. PubMed ID: 33327268
[TBL] [Abstract][Full Text] [Related]
7. An elevated neutrophil-lymphocyte ratio independently predicts mortality in chronic critical limb ischemia.
Spark JI; Sarveswaran J; Blest N; Charalabidis P; Asthana S
J Vasc Surg; 2010 Sep; 52(3):632-6. PubMed ID: 20573475
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy.
Kawahara T; Furuya K; Nakamura M; Sakamaki K; Osaka K; Ito H; Ito Y; Izumi K; Ohtake S; Miyoshi Y; Makiyama K; Nakaigawa N; Yamanaka T; Miyamoto H; Yao M; Uemura H
BMC Cancer; 2016 Mar; 16():185. PubMed ID: 26944862
[TBL] [Abstract][Full Text] [Related]
9. Novel immunological and nutritional-based prognostic index for gastric cancer.
Sun KY; Xu JB; Chen SL; Yuan YJ; Wu H; Peng JJ; Chen CQ; Guo P; Hao YT; He YL
World J Gastroenterol; 2015 May; 21(19):5961-71. PubMed ID: 26019461
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
11. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.
Ruan DY; Lin ZX; Li Y; Jiang N; Li X; Wu DH; Wang TT; Chen J; Lin Q; Wu XY
World J Gastroenterol; 2015 May; 21(18):5598-606. PubMed ID: 25987785
[TBL] [Abstract][Full Text] [Related]
12. Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer.
Kobayashi N; Usui S; Kikuchi S; Goto Y; Sakai M; Onizuka M; Sato Y
Lung Cancer; 2012 Feb; 75(2):223-7. PubMed ID: 21764477
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-Lymphocyte Ratio in Different Stages of Breast Cancer.
Elyasinia F; Keramati MR; Ahmadi F; Rezaei S; Ashouri M; Parsaei R; Yaghoubi M; Elyasinia F; Aboutorabi A; Kaviani A
Acta Med Iran; 2017 Apr; 55(4):228-232. PubMed ID: 28532133
[TBL] [Abstract][Full Text] [Related]
14. Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma.
Ben Q; An W; Wang L; Wang W; Yu L; Yuan Y
Pancreas; 2015 Apr; 44(3):471-7. PubMed ID: 25423560
[TBL] [Abstract][Full Text] [Related]
15. Hyperfibrinogen Is Associated With the Systemic Inflammatory Response and Predicts Poor Prognosis in Advanced Pancreatic Cancer.
Qi Q; Geng Y; Sun M; Chen H; Wang P; Chen Z
Pancreas; 2015 Aug; 44(6):977-82. PubMed ID: 25931258
[TBL] [Abstract][Full Text] [Related]
16. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer.
Pathmanathan N; Balleine RL; Jayasinghe UW; Bilinski KL; Provan PJ; Byth K; Bilous AM; Salisbury EL; Boyages J
J Clin Pathol; 2014 Mar; 67(3):222-8. PubMed ID: 24403187
[TBL] [Abstract][Full Text] [Related]
18. The association between neutrophil to lymphocyte ratio and survival in metastatic breast cancer patients.
Unlu O; Petekkaya E; Ozcan B; Altundag K
J BUON; 2016; 21(5):1322-1323. PubMed ID: 27837641
[No Abstract] [Full Text] [Related]
19. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy.
Gondo T; Nakashima J; Ohno Y; Choichiro O; Horiguchi Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
Urology; 2012 May; 79(5):1085-91. PubMed ID: 22446338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
